The global Lidocaine Ointment Market Growth Accelerated by Rapid Penetration of Topical Solutions
Lidocaine ointment is a topical medication used to temporarily reduce pain, itching, or discomfort from skin irritations, minor burns, sunburn, insect bites, eczema, poison ivy, poison oak, or poison sumac. It works by blocking nerve impulses (numbing) in the skin and it involves less risk of unintended absorption compared to oral medications. The increasing adoption of topical solutions for minor wounds, skin abrasions and irritation has significantly drove the demand for lidocaine ointment over the forecast period.
The global Lidocaine Ointment Market is estimated to be
valued at US$ 1,275.2 Mn in 2023 and is expected to exhibit a CAGR of 7.7% over
the forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
The rapid penetration of topical solutions for pain management, especially in
developed regions is a key trend in the global lidocaine ointment market.
Topical analgesics like lidocaine are preferred over oral medications owing to
advantages such as localized action, minimal side effects and lower interaction
risks with other drugs. In addition, factors such as rising consumer preference
for over-the-counter drugs, strong online presence of pharmaceutical retailers
and growing preference for self-medication are contributing to widespread
adoption of lidocaine ointment for minor skin ailments over the forecast
period. The market is expected to witness strong growth with rise in
self-medication and inclination towards topical drugs for minor injuries and
pain.
Segment
Analysis
The global lidocaine
ointment market is dominated by the 5% lidocaine ointment segment, which
accounts for nearly 70% share of the overall market. This is because 5%
lidocaine concentration provides effective relief from pain associated with
post-herpetic neuralgia and superficial burns without major side effects.
Higher concentrations can cause methemoglobinemia in some cases.
Key Takeaways
The global lidocaine ointment market is expected to witness high growth over
the forecast period of 2023-2030. Factors such as growing incidence of shingles
and burn injuries along with increasing prevalence of nerve pain disorders are
expected to drive market growth. The global Lidocaine Ointment Market is
estimated to be valued at US$ 1,275.2 Mn in 2023 and is expected to exhibit a
CAGR of 7.7% over the forecast period 2023 to 2030.
Regional analysis- North America currently dominates the global market and is expected to continue its dominance over the forecast period. This is attributed to rising healthcare expenditure and presence of major players in the region. However, Asia Pacific is expected to witness highest growth during the forecast period owing to rapidly increasing patient population, growing medical tourism, and rising generic drug production in the region.
Key players- Key players operating in the lidocaine ointment market include Glenmark Pharmaceuticals U.S. Inc., Teligent Inc., Taro Pharmaceutical Industries Ltd., CENTURA PHARMACEUTICALS INC., Neon Laboratories Ltd., ASTRAZENECA CANADA INC., Novocol Pharma, Amneal Pharmaceuticals LLC., Alembic Pharmaceuticals Limited, Ascend Laboratories LLC, Liberty Pharmaceuticals, Inc., Hi-Tech Pharmaceuticals, Aspen Pharmacare Australia Pty Ltd., Sandoz AG, Zydus Healthcare Limited., Quagen Pharmaceuticals, Zuche Pharmaceuticals Private Limited., and SEPTODONT, Inc. Major players are focusing on new product launches and geographical expansion to strengthen their market position.
Comments
Post a Comment